Early detection of lung cancer through analysis of VOC biomarkers in exhaled breath: The LuCID study. Source: International Congress 2017 – Lung cancer: clinical research on exhaled breath, clinical trials in advanced NSCLC and real-life appraisals of immunotherapies Year: 2017
Lung disease diagnostic method based on proteomic analysis of exhaled breath condensate Source: International Congress 2019 – Basic research of airway diseases Year: 2019
Diagnosis of lung diseases based on proteomic analysis of exhaled breath condensate Source: International Congress 2017 – Clinical problems in lung diseases Year: 2017
Exhaled biomarkers in lung cancer Source: Eur Respir J 2009; 34: 261-275 Year: 2009
Exhaled breath analysis by use of eNose technology: a novel diagnostic tool for interstitial lung disease Source: Eur Respir J, 57 (1) 2002042; 10.1183/13993003.02042-2020 Year: 2021
Is NMR-based metabolomic analysis of exhaled breath condensate accurate? Source: Eur Respir J 2011; 37: 468 Year: 2011
SELDI-TOF MS for proteomic analysis of exhaled breath condensate from patients with pulmonary emphysema Source: Annual Congress 2009 - COPD: basic science and clinical studies Year: 2009
Metabolomic analysis of exhaled breath condensate in diagnostics of obstructive airway diseases Source: Annual Congress 2011 - Role of the biomarkers in airway diseases Year: 2011
Metabolomic/proteomic analysis of biomarkers in exhaled breath condensates Source: Annual Congress 2008 - PG8 - Cellular and molecular technologies of today - treatments of tomorrow Year: 2008
Non-invasive lung cancer diagnosis by detection of GATA6 and NKX2-1 isoforms in exhaled breath condensate Source: International Congress 2017 – Clinical research in lung cancer: new valuable results on lung cancer detection, prognostic biomarkers, and tyrosine kinase inhibitors Year: 2017
Is the analysis of torbamycin in exhaled breath condensate a diagnostic tool to monitor pulmonary drug deposition? Source: Eur Respir J 2004; 24: Suppl. 48, 386s Year: 2004
Processing optimization of exhaled breath condensate previous to the analysis by mass spectrometry Source: Annual Congress 2012 - Mechanics, muscles and movement: aspects of airway mechanics, repiratory muscle assessment and field exercise tests Year: 2012
Better characterization of local inflammation in COPD: detection of new biomarkers in exhaled breath condensate Source: Eur Respir J 2006; 28: Suppl. 50, 747s Year: 2006
Technical problems with measurements of biomarkers - exhaled breath condensate Source: ERS Skills course - Biomarkers and functional assessment of obstructive lung diseases Year: 2017
Protein markers in the exhaled breath condensate of lung carcinoma patients Source: Annual Congress 2012 - Exhaled biomarkers in airway diseases Year: 2012
The use of electronic nose technology for the detection of Lung Cancer (LC): analysis of exhaled volatile compounds by Aeonose® Source: International Congress 2018 – Lung cancer: from early diagnosis to modern monitoring strategies Year: 2018
Proteins in exhaled breath condensate: identification and pattern Source: Annual Congress 2007 - Noninvasive evaluation of airway diseases Year: 2007
Exhaled breath condensate sample collection: standards and open issues Source: Eur Respir Monogr 2010; 49: 152-161 Year: 2010
Simultaneous measurement of inhaled air and exhaled breath by double multicapillary column ion-mobility spectrometry, a new method for breath analysis: results of a feasibility study Source: ERJ Open Res, 8 (1) 00493-2021; 10.1183/23120541.00493-2021 Year: 2022
Detection of lung cancer using expired breath analysis by ion mobility spectrometry Source: International Congress 2015 – Developments in lung cancer diagnosis Year: 2015